Skip to main navigation Skip to search Skip to main content

Ustekinumab as induction and maintenance therapy for Crohn's disease

  • UNITI-IM-UNITI Study Group

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Ustekinumab as induction and maintenance therapy for Crohn's disease'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science